Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.530
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
2.531
+0.001 (0.02%)
After-hours: Dec 20, 2024, 4:01 PM EST
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $73.05 million as of December 20, 2024. Its market cap has decreased by -84.14% in one year.
Market Cap
73.05M
Enterprise Value
-15.14M
1-Year Change
-84.14%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $73.05M, a decrease of -77.42%. That is a compound annual growth rate of -34.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 73.05M | -88.33% |
| Dec 29, 2023 | 626.15M | -13.15% |
| Dec 30, 2022 | 720.93M | 150.50% |
| Dec 31, 2021 | 287.80M | -11.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genelux | 74.69M |
| Rani Therapeutics Holdings | 74.66M |
| Unicycive Therapeutics | 73.70M |
| Ovid Therapeutics | 72.43M |
| Generation Bio Co. | 72.14M |
| Armata Pharmaceuticals | 71.64M |
| Owlet | 71.52M |
| Vicarious Surgical | 71.08M |